Repare Therapeutics Inc. - Common shares, no par value (RPTX)

CUSIP: 760273102

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common shares, no par value
Shares outstanding
42,837,925
Total 13F shares
35,816,579
Share change
+2,612,954
Total reported value
$379,155,366
Put/Call ratio
28%
Price per share
$10.58
Number of holders
77
Value change
+$27,699,133
Number of buys
31
Number of sells
32

Quarterly Holders Quick Answers

What is CUSIP 760273102?
CUSIP 760273102 identifies RPTX - Repare Therapeutics Inc. - Common shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of RPTX - Repare Therapeutics Inc. - Common shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of Repare Therapeutics Inc. - Common shares, no par value (RPTX) as of Q2 2023

As of 30 Jun 2023, Repare Therapeutics Inc. - Common shares, no par value (RPTX) was held by 77 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,816,579 shares. The largest 10 holders included BVF INC/IL, ORBIMED ADVISORS LLC, CHI Advisors LLC, Deep Track Capital, LP, Versant Venture Management, LLC, ARK Investment Management LLC, Redmile Group, LLC, MPM ASSET MANAGEMENT LLC, T. Rowe Price Investment Management, Inc., and BIOIMPACT CAPITAL LLC. This page lists 77 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
77
Q2 2023 holders
77
Holder diff
0
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 Value $ Q2 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .